The syndrome is caused by a mutation in the fibrillin-1 (FBN1) gene, with a mutation frequency of 12.7% [145]; furthermore, a mutation in this gene may occur in AAA with a frequency of 5% [146]. The gene discussed is FBN1; the disease is triple-A syndrome.